Company: CPSH
Filing Date: 2025-10-08
Form Type: 424B5
Source: 0001437749-25-030673
Chunk: 6

Company: CPS TECHNOLOGIES CORP/DE/
Filing Date: 2025-10-08
Form: 424B5
Chunk 6
---
421,400 shares of common stock reserved for future issuance of awards pursuant to the Company’s 2020 Equity Incentive Plan. |

Unless otherwise indicated, this prospectus assumes no exercise of outstanding stock options or warrants and no settlement of outstanding restricted stock units.

<div align='center'>S-3

RISK FACTORS</div>

You should consider carefully the risks described below and discussed under the section captioned“Risk Factors”contained in our Annual Report on Form 10-K for the year ended December 28, 2024, and as updated by our subsequent filings under the Securities Exchange Act of 1934, as amended, or the Exchange Act, including our Quarterly Reports on Form 10-Q for the periods ended March 29, 2025 and June 28, 2025, which are incorporated by reference in this prospectus supplement and the accompanying prospectus in their entirety, together with other information in this prospectus supplement, the accompanying prospectus and the information and documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and any free writing prospectus that we have authorized for use in connection with this offering before you make a decision to invest in our common stock. If any of the following events actually occur, our business, operating results, prospects or financial condition could be materially and adversely affected. This could cause the trading price of our common stock to decline and you may lose all or part of your investment. The risks described below are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business operations.

Risks Related to our Common Stock and this Offering

We have broad discretion as to the use of proceeds from this offering and may not use the proceeds effectively.

We have not designated any portion of the net proceeds from this offering to be used for any particular purpose. Our management will retain broad discretion as to the allocation of the proceeds and may spend these proceeds in ways in which you may not agree. The failure of our management to apply these funds effectively could result in unfavorable returns and uncertainty about our prospects, each of which could cause the price of our common stock to decline.

If you purchase our common stock in this offering, you will incur immediate and substantial dilution in the book value of your shares.

If you purchase shares of our common stock in this offering, you will incur immediate dilution in the as adjusted net tangible book value of your shares of common stock to the extent the price that you pay is greater than